)
Exchange to launch cash-settled monthly futures and options on BSE Focused Midcap Index, widening its derivatives offerings
It is now for the industry associations to agitate the matter before the government
In the grey markets, shares of Mankind Pharma enjoyed a premium of Rs 90, which translated to a likely listing price of Rs 1,170 per share on the upper price band
The RBI need not match the Fed one-to-one but there seems little scope to take its foot off the gas